WEBINAR december 3, 2021 at 5 pm CET - Design and analysis of COVID vaccine trials: the familiar and the strange.

This webinar was the first step of SnB2022. Many thanks to all the participants and to the guests speakers Stephen Senn and Holly Janes.


Stephen Senn gave a general presentation on the trials performed to evaluate COVID19 vaccines and described some choices such as sequential approach, 2:1 allocation, frequentist vs Bayesian.
The slide is available here.

Holly Janes developed one or two aspects such as choosing appropriate endpoints and long-term-assessment of vaccine efficacy with emergence of new variants.
The slide is available here.

The webinar is online on YouTube.


Focus on our guests speakers:

Stephen Senn, Phd. FRSE, CStat - Consultant Statistician, worked in the pharmaceutical industry, in the National Health Service, further education and medical research, specialized in statistical methods for designing and analysing drug development programmes and clinical trials.

Dr. Holly Janes is a biostatistician working on the design and analysis of vaccine studies, with a particular expertise in HIV and COVID prevention and vaccine science. She is co-PI of the Statisics and Data Management Center of the HIV Vaccine Trials Network and a key investigator in the newly-formed USG-funded COVID Prevention Network.